Sirios Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$58M |
| 2 |
HCA Healthcare
HCA
|
+$57M |
| 3 |
PTC
PTC
|
+$49.2M |
| 4 |
Microsoft
MSFT
|
+$29.5M |
| 5 |
Intel
INTC
|
+$28.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$76.5M |
| 2 |
Truist Financial
TFC
|
+$52.1M |
| 3 |
BJs Wholesale Club
BJ
|
+$44.1M |
| 4 |
Elanco Animal Health
ELAN
|
+$44.1M |
| 5 |
Union Pacific
UNP
|
+$34.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.31% |
| 2 | Technology | 25.47% |
| 3 | Financials | 11.76% |
| 4 | Industrials | 9.3% |
| 5 | Consumer Staples | 5.78% |
Similar funds
Sirios Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Sirios Capital Management held 78 positions worth $1.13B, down 27% from $1.55B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Sirios Capital Management withdrew a net $97.6M in Q1 2020, closing 8 positions and reducing 27 holdings. Its most notable exit was Check Point Software Technologies, an estimated $30.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 31% a quarter earlier, followed by Technology and Financials.
Against the trend, Sirios Capital Management opened a new position in Pfizer worth $52.7M.
- Sirios Capital Management's largest Q1 2020 buy was Pfizer: 1,701,663 shares worth $52.7M.
- Sirios Capital Management added most to HCA Healthcare in Q1 2020, an estimated $57M increase.
- Sirios Capital Management's biggest Q1 2020 reduction was JPMorgan Chase, cutting an estimated $76.5M.
- Sirios Capital Management fully exited Check Point Software Technologies in Q1 2020, selling an estimated $30.4M.
- Sirios Capital Management's ten largest holdings make up 43% of its $1.13B portfolio in Q1 2020.
- Sirios Capital Management opened 24 new positions and closed 8 in Q1 2020.
- Sirios Capital Management's portfolio value fell 27% quarter-over-quarter to $1.13B.
Based on Sirios Capital Management's 13F filing for Q1 2020, filed 15 May 2020.